Veronica Wiley

4.4k total citations · 1 hit paper
68 papers, 2.8k citations indexed

About

Veronica Wiley is a scholar working on Clinical Biochemistry, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Veronica Wiley has authored 68 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Clinical Biochemistry, 30 papers in Pediatrics, Perinatology and Child Health and 24 papers in Molecular Biology. Recurrent topics in Veronica Wiley's work include Metabolism and Genetic Disorders (32 papers), Neonatal Health and Biochemistry (27 papers) and Mitochondrial Function and Pathology (13 papers). Veronica Wiley is often cited by papers focused on Metabolism and Genetic Disorders (32 papers), Neonatal Health and Biochemistry (27 papers) and Mitochondrial Function and Pathology (13 papers). Veronica Wiley collaborates with scholars based in Australia, United States and United Kingdom. Veronica Wiley's co-authors include Bridget Wilcken, Kevin Carpenter, Judith Hammond, Michelle A. Farrar, Keow Giak Sim, Didu Kariyawasam, Sunita Bijarnia, Aidan McElduff, John Christodoulou and Marion Haas and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Veronica Wiley

67 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry

2003 512 citations Bridget Wilcken, Veronica Wiley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Veronica Wiley Australia	30	1.5k	1.2k	993	479	455	68	2.8k
Colleen Azen United States	30	1.1k 0.7×	717 0.6×	458 0.5×	312 0.7×	585 1.3×	78	2.4k
Martina Huemer Austria	26	1.3k 0.8×	855 0.7×	472 0.5×	227 0.5×	861 1.9×	74	2.4k
F. Maillot France	22	1.2k 0.8×	837 0.7×	290 0.3×	180 0.4×	523 1.1×	150	2.3k
J V Leonard United Kingdom	24	822 0.6×	598 0.5×	324 0.3×	197 0.4×	454 1.0×	69	1.8k
Marco Spada Italy	28	1.0k 0.7×	1.1k 1.0×	292 0.3×	214 0.4×	716 1.6×	132	3.1k
Philip Mayne Ireland	21	326 0.2×	275 0.2×	334 0.3×	258 0.5×	372 0.8×	71	1.3k
John H. Walter United Kingdom	20	1.2k 0.8×	874 0.8×	310 0.3×	210 0.4×	589 1.3×	39	1.9k
Sarah C. Grünert Germany	22	726 0.5×	716 0.6×	212 0.2×	277 0.6×	564 1.2×	86	1.6k
Pamela Arn United States	20	294 0.2×	361 0.3×	130 0.1×	592 1.2×	809 1.8×	36	1.8k
Bridget Wilcken Australia	18	623 0.4×	487 0.4×	258 0.3×	56 0.1×	353 0.8×	37	1.2k

Countries citing papers authored by Veronica Wiley

Since Specialization

Citations

This map shows the geographic impact of Veronica Wiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Wiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Wiley more than expected).

Fields of papers citing papers by Veronica Wiley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Wiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Wiley. The network helps show where Veronica Wiley may publish in the future.

Co-authorship network of co-authors of Veronica Wiley

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Wiley. A scholar is included among the top collaborators of Veronica Wiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Wiley. Veronica Wiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lain, Samantha J., et al.. (2023). Outcomes of lowered newborn screening thresholds for congenital hypothyroidism. Journal of Paediatrics and Child Health. 59(8). 955–961. 5 indexed citations

Wiley, Veronica, et al.. (2023). Genotyping in patients with congenital adrenal hyperplasia by sequencing of newborn bloodspot samples. Journal of Pediatric Endocrinology and Metabolism. 36(10). 966–973. 1 indexed citations

Shih, Sophy, Elena Keller, Veronica Wiley, et al.. (2022). Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency. International Journal of Neonatal Screening. 8(3). 44–44. 11 indexed citations

Shih, Sophy, Elena Keller, Veronica Wiley, et al.. (2022). Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency. International Journal of Neonatal Screening. 8(3). 45–45. 24 indexed citations

Ho, Gladys, Bruce Bennetts, Adviye Ayper Tolun, et al.. (2021). Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning. International Journal of Neonatal Screening. 7(2). 25–25. 8 indexed citations

Wiley, Veronica, et al.. (2021). Effect of Maternal Metformin Treatment in Pregnancy on Neonatal Metabolism: Evidence From Newborn Metabolic Screening. Diabetes Care. 44(11). 2536–2541. 8 indexed citations

Lain, Samantha J., Veronica Wiley, Michelle Jack, et al.. (2020). Association of elevated neonatal thyroid-stimulating hormone levels with school performance and stimulant prescription for attention deficit hyperactivity disorder in childhood. European Journal of Pediatrics. 180(4). 1073–1080. 10 indexed citations

Kariyawasam, Didu, et al.. (2019). The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Genetics in Medicine. 22(3). 557–565. 90 indexed citations

Wiley, Veronica, Bruce Bennetts, Louise Christie, et al.. (2018). Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study. International Journal of Neonatal Screening. 4(1). 9–9. 4 indexed citations

10.

Coffey, Michael J., Carolyn Shalhoub, S. L. Nightingale, et al.. (2017). Differences in Outcomes Between Early and Late Diagnosis of Cystic Fibrosis in the Newborn Screening Era. Obstetrical & Gynecological Survey. 72(6). 328–330. 1 indexed citations

11.

Robinson, Paul D., et al.. (2015). Long-Term Outcomes of Children with Intermediate Sweat Chloride Values in Infancy. The Journal of Pediatrics. 166(6). 1469–1474.e3. 46 indexed citations

12.

Christie, Louise, Bruce Bennetts, Veronica Wiley, et al.. (2013). Maternal attitudes to newborn screening for fragile X syndrome. American Journal of Medical Genetics Part A. 161(2). 301–311. 25 indexed citations

13.

Mullins, Raymond J, Sunday Clark, Veronica Wiley, Darryl W. Eyles, & Carlos A. Camargo. (2012). Neonatal vitamin D status and childhood peanut allergy: a pilot study. Annals of Allergy Asthma & Immunology. 109(5). 324–328. 24 indexed citations

14.

Wilcken, Bridget, Pamela Joy, Veronica Wiley, et al.. (2009). NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY: A COHORT STUDY COMPARING OUTCOME IN SCREENED AND CLINICALLY DIAGNOSED PATIENTS AT SIX YEARS OF AGE. Molecular Genetics and Metabolism. 98. 3–3. 1 indexed citations

15.

Haas, Marion, et al.. (2007). Healthcare Use and Costs of Medium-chain Acyl-Coa Dehydrogenase Deficiency in Australia: Screening Versus No Screening. The Journal of Pediatrics. 151(2). 121–126.e1. 18 indexed citations

16.

Wilcken, Bridget, Marion Haas, Pamela Joy, et al.. (2007). Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. The Lancet. 369(9555). 37–42. 127 indexed citations

17.

Waddell, Leigh B., Veronica Wiley, Kevin Carpenter, et al.. (2005). Medium-chain acyl-CoA dehydrogenase deficiency: Genotype–biochemical phenotype correlations. Molecular Genetics and Metabolism. 87(1). 32–39. 74 indexed citations

18.

Wilcken, Bridget & Veronica Wiley. (2003). Newborn screening methods for cystic fibrosis. Paediatric Respiratory Reviews. 4(4). 272–277. 32 indexed citations

19.

Carpenter, Kevin & Veronica Wiley. (2002). Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clinica Chimica Acta. 322(1-2). 1–10. 74 indexed citations

20.

Wilcken, Bridget, et al.. (1995). Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies. The Journal of Pediatrics. 127(6). 965–970. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact